Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

215.47B

Market cap215.47B

Price-Earnings ratio

11.45

Price-Earnings ratio11.45

Dividend yield

2.62%

Dividend yield2.62%

Average volume

11.49M

Average volume11.49M

High today

$48.50

High today$48.50

Low today

$47.55

Low today$47.55

Open price

$47.84

Open price$47.84

Volume

8.73M

Volume8.73M

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

TipRanks 27m

Novo Nordisk price target raised to DKK 275 from DKK 250 at JPMorgan

JPMorgan raised the firm’s price target on Novo Nordisk (NVO) to DKK 275 from DKK 250 and keeps a Neutral rating on the shares. Published first on TheFly – the...

24/7 Wall St. 2h

Eli Lilly vs Novo Nordisk: One Winner in The Weight-Loss Drug Gold Rush

Eli Lilly vs Novo Nordisk: One Winner in The Weight-Loss Drug Gold Rush By Vandita Jadeja Published Aug 25, 10:30AM EDT Quick Read LLY posted 48% revenue grow...

Investing.com 6h

J.P. Morgan raises Novo Nordisk target on stronger Ozempic, Wegovy sales - Investing.com

...

More NVO News

TipRanks 24h

Novo Nordisk’s AMAZE 9 Oral Obesity Trial: A New Pill in the Weight-Loss Race

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident i...

TipRanks 1d

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

TipRanks 1d

Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851

Lexicon (LXRX) announced that it has earned a third $10M milestone payment in 2026 from Novo Nordisk (NVO) following the achievement of a patient dosing milesto...

Nasdaq 2d

Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can

Key Points Rhythm Pharmaceuticals develops medicines for rare forms of obesity. The company has little competition in its target market. The stock looks prom...

TipRanks 3d

Veru Inc Earnings Call Highlights Obesity Trial Momentum

Veru Inc ((VERU)) has held its Q3 earnings call. Read on for the main highlights of the call. Summer Sale - Claim 70% Off TipRanks Unlock powerful investing too...

Simply Wall St 4d

Novo Nordisk Stock And 2 Dividend Growers With Strong Cash Flow

Eurozone manufacturing and services activity are both improving in 2026, with composite growth at a nine month high. That kind of steady economic pulse often ke...

Simply Wall St 5d

Is Novo Nordisk Undervalued As Oral Semaglutide Progress Shapes Its Growth Story?

Novo Nordisk (NYSE:NVO) continues to attract attention as investors weigh its role in obesity and diabetes care against recent share price moves. The stock clos...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.